BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 30275174)

  • 1. Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
    Park R; Williamson S; Kasi A; Saeed A
    Anticancer Res; 2018 Oct; 38(10):5569-5580. PubMed ID: 30275174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising immunotherapies for esophageal cancer.
    Tanaka T; Nakamura J; Noshiro H
    Expert Opin Biol Ther; 2017 Jun; 17(6):723-733. PubMed ID: 28366014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer.
    Vrána D; Matzenauer M; Neoral Č; Aujeský R; Vrba R; Melichar B; Rušarová N; Bartoušková M; Jankowski J
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Immunotherapy in Advanced Gastroesophageal Cancer.
    Terrero G; Lockhart AC
    Curr Oncol Rep; 2020 Aug; 22(11):112. PubMed ID: 32803457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for esophageal squamous cell carcinoma: a review.
    Mimura K; Yamada L; Ujiie D; Hayase S; Tada T; Hanayama H; Thar Min AK; Shibata M; Momma T; Saze Z; Ohki S; Kono K
    Fukushima J Med Sci; 2018 Aug; 64(2):46-53. PubMed ID: 30058598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.
    Alsina M; Moehler M; Lorenzen S
    Oncol Res Treat; 2018; 41(5):266-271. PubMed ID: 29705786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for oesophagogastric cancer.
    Davidson M; Chau I
    Expert Opin Biol Ther; 2016 Oct; 16(10):1197-207. PubMed ID: 27409159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of cancer immunotherapy for esophageal squamous cell carcinoma.
    Kono K; Mimura K; Yamada R; Ujiie D; Hayase S; Tada T; Hanayama H; Min AKT; Shibata M; Momma T; Saze Z; Ohki S
    Esophagus; 2018 Jan; 15(1):1-9. PubMed ID: 29892809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging immunotherapy for the treatment of esophageal cancer.
    Jackie Oh S; Han S; Lee W; Lockhart AC
    Expert Opin Investig Drugs; 2016 Jun; 25(6):667-77. PubMed ID: 26950826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for esophageal cancer: a 2019 update.
    Schizas D; Charalampakis N; Kole C; Mylonas KS; Katsaros I; Zhao M; Ajani JA; Psyrri A; Karamouzis MV; Liakakos T
    Immunotherapy; 2020 Feb; 12(3):203-218. PubMed ID: 32208794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and Future Aspects of Immunotherapy for Esophageal and Gastric Malignancies.
    De Mello RA; Lordick F; Muro K; Janjigian YY
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():237-247. PubMed ID: 31099644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoints aberrations and gastric cancer; assessment of prognostic value and evaluation of therapeutic potentials.
    Abdel-Rahman O
    Crit Rev Oncol Hematol; 2016 Jan; 97():65-71. PubMed ID: 26321371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Checkpoint Blockade in Breast Cancer Therapy.
    Bu X; Yao Y; Li X
    Adv Exp Med Biol; 2017; 1026():383-402. PubMed ID: 29282694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Current Status of Immunotherapies in Esophagogastric Cancer.
    Ku GY
    Hematol Oncol Clin North Am; 2019 Apr; 33(2):323-338. PubMed ID: 30833003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Immunotherapy in Esophagogastric Cancer.
    Jazieh K; Yoon H; Zhu M
    Hematol Oncol Clin North Am; 2024 Jun; 38(3):599-616. PubMed ID: 38493074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapeutic advances in gastric cancer.
    Yoneda A; Kuroki T; Eguchi S
    Surg Today; 2021 Nov; 51(11):1727-1735. PubMed ID: 33590326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.
    Bolm L; Käsmann L; Paysen A; Karapetis C; Rades D; Wellner UF; Keck T; Watson DI; Hummel R; Hussey DJ
    Anticancer Res; 2018 Jun; 38(6):3231-3242. PubMed ID: 29848670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical research progress of cell immunity in gastric cancer].
    Xu RH; Wu J; Chen M; Zou X; Liu SL
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):321-325. PubMed ID: 31137163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer.
    Jin X; Liu Z; Yang D; Yin K; Chang X
    Front Immunol; 2022; 13():948647. PubMed ID: 35844558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of gastric cancer: Past, future perspective and challenges.
    Xie J; Fu L; Jin L
    Pathol Res Pract; 2021 Feb; 218():153322. PubMed ID: 33422778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.